ESC 365 - Therapeutic Options Targeting Residual CVD Risk: Current Therapies for the Treatment of Dyslipidemia.

ESC Premium Access

Therapeutic Options Targeting Residual CVD Risk: Current Therapies for the Treatment of Dyslipidemia.

Session: Prevention 360: Strategies for Managing Cardiovascular Risk

Topic: Primary cardiovascular prevention: interventions and outcomes

Speaker: Professor S. Nicholls (Melbourne, AU)

Sponsored by Cleveland Clinic

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Stephen Nicholls

Monash University, Melbourne (Australia)

53 presentations

5 followers

3 more presentations in this session

What is optimal BP? Key differences and controversies among the many guidelines.

Speaker: Doctor L. Cho (Cleveland, US)

Glucose lowering agents in the Prevention of Cardiovascular events and Mortality in Type II Diabetes.

Speaker: Doctor V. Menon (Cleveland, US)

Pharmacotherapy Options for Obesity and Cardiometabolic Risk: Helpful or Harmful?

Speaker: Professor S. Nissen (Cleveland, US)

Access the full session

Prevention 360: Strategies for Managing Cardiovascular Risk

Speakers: Professor S. Nicholls, Doctor L. Cho, Doctor V. Menon, Professor S. Nissen

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources